The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin Amyloidosis

计划入组 21 人 · 首次发布于 2008 年 3 月 7 日

EOSS-ATTR Study (eHealth Based Operative Support System in ATTR-CM)

计划入组 50 人 · 首次发布于 2024 年 7 月 12 日

Transthyretin Amyloidosis Outcome Survey (THAOS)

计划入组 6,718 人 · 首次发布于 2008 年 3 月 5 日

Transthyretin Amyloidosis Therapy (HuidaGene)

TTR gene therapy (transthyretin amyloidosis)

CRISPR-Cas12 gene therapy (HG-PRECISE, Transthyretin Amyloidosis)

Associated Capital

United States

Associated Medical Supplies Ltd

Canada

Associated Clinicians of East Texas, PLLC

United States

EU Approves WAINZUA (Eplontersen) for Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy

Attralus' Zamubafusp Alfa Receives FDA Orphan Drug Designation for AL Amyloidosis

Swissmedic Authorizes Tegsedi for Hereditary Transthyretin Amyloidosis